1.Li MH, .., L. Sun. “Next generation of anti-PD-L1 Atezolizumab with more enhanced anti-tumor efficacy in vivo”, Scientific Reports, 2021.  IF=3.998

2.Ren WL, ..L. Sun. “A COVID-19 vaccine based on the spike S1 protein with a novel adjuvant induces high level of neutralizing responses in nonhuman primates” Vaccine (2020) IF=3.23

3.R.Q. Zhao, .., L.Sun. “Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection” Clinical Infectious Diseases (2020) IF=8.313

4.R.Q. Zhao, .., L.Sun “Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy”, Antibody Therapeutics (2020)

5.R.Q. Zhao, .., L.Sun, “Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects” Vaccine 37 (2019) IF3.269

6.M.H.Li, .. L. Sun, “Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA” J Immunol Methods (2019)

7.Xiao Q, Wu J, et al. Wu D. “DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation” Nature Medicine (2018) IF=30.67

8.M.H. Li , H.Z.Li ,et al., L. Sun. “A simple and cost-effective assay for measuring anti-drug antibody in human patients treated with Adalimumab” J Immunol Methods (2018) 

9.L.Mi, W.Li, et al., L. Sun, Z.N.Chen. “Immunogenicity Screening Assay Development for a Novel Human-Mouse Chimeric Anti-CD147 Monoclonal Antibody (Metuzumab) ” J Immunol Methods (2016)